I think this preprint title reveals a lot about Anthropic's approach to science.
Scientific paper titles basically never mention the tools used to make the discoveries they report. The focus is on what was discovered.
For example:
- "A Structure for Deoxyribose Nucleic Acid" (Watson & Crick)
- "Streptomycin, a Substance Exhibiting Antibiotic Activity against Gram-Positive and Gram-Negative Bacteria" (Waksman)
- "A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity" (Doudna & Charpentier)
- "Design of a Novel Globular Protein Fold with Atomic-Level Accuracy" (Baker)
In each of these, the discovery / key deliverable is front and center. The machines, methods, and people used to make that discovery do not get mentioned because they're not the point. The discovery is what matters.
Yet, here, Anthropic chose to title their preprint "Autonomous AI agents discover reverse transcriptases with tandem repeat arrays."
That's not a scientific paper title: that is a headline.
It puts the discovery secondary to the fact that "Autonomous AI agents" made it. If they were serious about putting science first, the fact that AI agents found a new enzyme would be no more important than if Taylor Swift did.
This choice gives the game away. Though this is dressed-up as a scientific paper, it is not. It is a press release.
Claude has discovered a previously unknown enzyme system hidden in the DNA of bacteriophages. Beside the enzyme’s gene sits a long array of repeating DNA—a structure that looks somewhat similar to CRISPR.
We don’t yet understand what this system does, but only a handful of known systems share its features, and all of them are able to cut, copy, and paste DNA. Historically, the discovery of such programmable systems has helped revolutionize medicine. CRISPR, for instance, is now the foundation of genetic medicines. But it will take much more work to learn what this system does, and whether it can be put to similar use.
Read more:
anthropic.com/news/claude-di…